EVO
Evotec SE ADRKey Statistics
About Evotec SE ADR
Evotec SE is a prominent global biotechnology firm headquartered in Hamburg, Germany, specializing in end-to-end drug discovery and development solutions for the pharmaceutical and biotech industries. The company employs a synergistic approach, collaborating with both established pharmaceutical giants and cutting-edge academic institutions to accelerate the advancement of a diverse range of therapeutic programs, including small molecules, biologics, and cell therapies. With a strong and growing pipeline of projects, Evotec is strategically positioned to leverage emerging opportunities in the biopharmaceutical landscape, reinforcing its essential role in driving healthcare innovation and improving patient outcomes.
Fundamentals
| Revenue (TTM) | $788.37M |
| Gross Profit (TTM) | $114.22M |
| EBITDA | $8.74M |
| Operating Margin | 9.17% |
| Return on Equity | -11.70% |
| Return on Assets | -2.28% |
| Revenue/Share (TTM) | $2.22 |
| Book Value | $2.70 |
| Price-to-Book | 1.18 |
| Price-to-Sales (TTM) | 1.42 |
| EV/Revenue | 1.186 |
| EV/EBITDA | 34.43 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 14.50% |
| Shares Outstanding | $355.19M |
| Float | $133.73M |
| % Insiders | 0.00% |
| % Institutions | 2.63% |
Historical Volatility
Volatility is currently expanding